[1] |
Manini I, Trombetta CM, Lazzeri G, et al. Egg-independent influenza vaccines and vaccine candidates[J]. Vaccines(Basel), 2017,5(3):18.
|
[2] |
Girard MP, Tam JS, Assossou OM, et al. The 2009 A(H1N1)influenza virus pandemic:A review[J]. Vaccine, 2010,28(31):4895-4902.
URL
pmid: 20553769
|
[3] |
McLean KA, Goldin S, Nannei C, et al. The 2015 global production capacity of seasonal and pandemic influenza vaccine[J]. Vaccine, 2016,34(45):5410-5413.
URL
pmid: 27531411
|
[4] |
Yamayoshi S, Kawaoka Y. Current and future influenza vaccines[J]. Nat Med, 2019,25(2):212-220.
URL
pmid: 30692696
|
[5] |
Konstantinov K, Goudar C, Ng M, et al. The “Push-to-Low” approach for optimization of high-density perfusion cultures of animal cells[J]. Cell Culture Engineering, 2006,101:75-98.
|
[6] |
Tapia F, Vazquez-Ramirez D, Genzel Y, et al. Bioreactors for high cell density and continuous multi-stage cultivations:options for process intensification in cell culture-based viral vaccine production[J]. Appl Microbiol Biotechnol, 2016,100(5):2121-2132.
|
[7] |
Bissinger T, Fritsch J, Mihut A, et al. Semi-perfusion cultures of suspension MDCK cells enable high cell concentrations and efficient influenza A virus production[J]. Vaccine, 2019,37(47):7003-7010.
|
[8] |
Granicher G, Coronel J, Pralow A, et al. Vaccine, 2019,37(47):7019-7028.
URL
pmid: 31005427
|
[9] |
Genzel Y, Vogel T, Buck J, et al. High cell density cultivations by alternating tangential flow(ATF)perfusion for influenza A virus production using suspension cells[J]. Vaccine, 2014,32(24):2770-2781.
|
[10] |
Petiot E, Jacob D, Lanthier S, et al. Metabolic and kinetic analyses of influenza production in perfusion HEK293 cell culture[J]. BMC Biotechnol, 2011,11:84.
URL
pmid: 21884612
|
[11] |
Genzel Y, Reichl U. Continuous cell lines as a production system for influenza vaccines[J]. Expert Rev Vaccines, 2009,8(12):1681-1692.
URL
pmid: 19943763
|
[12] |
黄锭, 刘旭平, 范里, 等. 感染时间对MDCK细胞中H1N1甲型流感病毒扩增过程的影响[J]. 生物技术通报, 2015,31(11):243-250.
|
|
Huang D, Liu XP, Li F, et al. Effects of TOI on H1N1 virus propagation in MDCK cell culture[J]. Biotechnology Bulletin, 2015,31(11):243-250.
|
[13] |
Kalbfuss B, Knöchlein A, Kröber T, et al. Monitoring influenza virus content in vaccine production:Precise assays for the quantitation of hemagglutination and neuraminidase activity[J]. Biologicals, 2008,36(3):145-161.
|
[14] |
Genzel Y, Reichl U. Vaccine production[M]//Animal Cell Biotechnology:Methods and Protocols. Totowa NJ: Humana Press, 2007: 457-473.
|
[15] |
Milian E, Kamen AA. Current and emerging cell culture manufacturing technologies for influenza vaccines[J]. Biomed Res Int, 2015: 504831.
URL
pmid: 33150167
|
[16] |
谢盼, 叶倩, 刘旭平, 等. 流感病毒生产的维持培养基开发及细胞代谢特征分析[J]. 生物技术通报, 2019,35(5):133-139.
|
|
Xie P, Ye Q, Liu XP, et al. Development of maintenance medium using for influenza virus production and analysis of cellular metabolic characteristics[J]. Biotechnology Bulletin, 2019,35(5):133-139.
|
[17] |
Gallo-Ramirez LE, Nikolay A, Genzel Y, et al. Bioreactor concepts for cell culture-based viral vaccine production[J]. Expert Rev Vaccines, 2015,14(9):1181-1195.
doi: 10.1586/14760584.2015.1067144
URL
pmid: 26178380
|
[18] |
Frensing T, Pflugmacher A, Bachmann M, et al. Impact of defective interfering particles on virus replication and antiviral host response in cell culture-based influenza vaccine production[J]. Appl Microbiol Biotechnol, 2014,98(21):8999-9008.
URL
pmid: 25132064
|
[19] |
Le Ru A, Jacob D, Transfiguracion J, et al. Scalable production of influenza virus in HEK-293 cells for efficient vaccine manufacturing[J]. Vaccine, 2010,28(21):3661-3671.
URL
pmid: 20347632
|
[20] |
Genzel Y, Dietzsch C, Rapp E, et al. MDCK and vero cells for influenza virus vaccine production:a one-to-one comparison up to lab-scale bioreactor cultivation[J]. Appl Microbiol Biotechnol, 2010,88(2):461-475.
URL
pmid: 20617311
|
[21] |
Nikolay A, Leon A, Schwamborn K, et al. Process intensification of EB66 cell cultivations leads to high-yield yellow fever and Zika virus production[J]. Appl Microbiol Biotechnol, 2018,102(20):8725-8737.
|
[22] |
Huang D, Peng WJ, Ye Q, et al. Serum-free suspension culture of MDCK cells for production of influenza H1N1 vaccines[J]. PLoS One, 2015,10(11):e0141686.
|
[23] |
Lohr V, Genzel Y, Behrendt I, et al. A new MDCK suspension line cultivated in a fully defined medium in stirred-tank and wave bioreactor[J]. Vaccine, 2010,28(38):6256-6264.
URL
pmid: 20638458
|
[24] |
Wolf MKF, Lorenz V, Karst DJ, et al. Development of a shake tube-based scale-down model for perfusion cultures[J]. Biotechnology and Bioengineering, 2018,115(11):2703-2713.
|
[25] |
Wang H, Guo S, Li Z, et al. Suspension culture process for H9N2 avian influenza virus(strain Re-2)[J]. Archives of Virology, 2017,162(10):3051-3059.
doi: 10.1007/s00705-017-3460-8
URL
pmid: 28685290
|